Low Dose Radiotherapy Combined With Sintilimab and Chemotherapy as Neoadjuvant Therapy for Stage II-III NSCLC
Clinical trial NCT06714708 · RECRUITING
Trial details
- NCT number
- NCT06714708
- Sponsor
- Anhui Provincial Cancer Hospital
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-20
- Primary completion
- 2026-12-01
- Enrollment
- 86
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.